Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
Clinical trial NCT03440112 · COMPLETED
Trial details
- NCT number
- NCT03440112
- Sponsor
- Nicolaas Bohnen, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2021-12-08
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.